Sevoflurane

About Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine Co., Ltd. is a leading Chinese pharmaceutical company founded in 1970, headquartered in Lianyungang, Jiangsu Province. The company has evolved from producing generic drugs to becoming a major innovator in oncology, with particular strength in developing novel cancer treatments, anesthesia drugs, and medical imaging contrast agents. Hengrui has established itself as one of China's most valuable pharmaceutical companies with significant R&D investments and an expanding global footprint.

About Piramal Pharma

Piramal Pharma is a leading, diversified global pharmaceutical company headquartered in India, structured into three core business verticals: Contract Development and Manufacturing (CDMO), Complex Hospital Generics, and Consumer Healthcare. The company leverages its expertise in complex chemistry and manufacturing to serve a global client base, including major pharmaceutical innovators. Its strategic focus is on high-growth, niche segments like injectables, oncology, and critical care, supported by a network of over 15 manufacturing facilities worldwide. The company was demerged from Piramal Enterprises and listed separately in 2022 to unlock value and drive focused growth.

Therapeutic Areas